IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
Title:
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
Author:
Rini, Brian I Stenzl, Arnulf Zdrojowy, Romauld Kogan, Mikhail Shkolnik, Mikhail Oudard, Stephane Weikert, Steffen Bracarda, Sergio Crabb, Simon J Bedke, Jens Ludwig, Joerg Maurer, Dominik Mendrzyk, Regina Wagner, Claudia Mahr, Andrea Fritsche, Jens Weinschenk, Toni Walter, Steffen Kirner, Alexandra Singh-Jasuja, Harpreet Reinhardt, Carsten Eisen, Tim